[go: up one dir, main page]

GB201306413D0 - The local treatment of ophthalmic diseases - Google Patents

The local treatment of ophthalmic diseases

Info

Publication number
GB201306413D0
GB201306413D0 GB201306413A GB201306413A GB201306413D0 GB 201306413 D0 GB201306413 D0 GB 201306413D0 GB 201306413 A GB201306413 A GB 201306413A GB 201306413 A GB201306413 A GB 201306413A GB 201306413 D0 GB201306413 D0 GB 201306413D0
Authority
GB
United Kingdom
Prior art keywords
local treatment
ophthalmic diseases
ophthalmic
diseases
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201306413A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cresset Biomolecular Discovery Ltd
Original Assignee
Cresset Biomolecular Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cresset Biomolecular Discovery Ltd filed Critical Cresset Biomolecular Discovery Ltd
Priority to GB201306413A priority Critical patent/GB201306413D0/en
Publication of GB201306413D0 publication Critical patent/GB201306413D0/en
Priority to JP2016507059A priority patent/JP2016516762A/en
Priority to GB1406390.3A priority patent/GB2516137B/en
Priority to AU2014252808A priority patent/AU2014252808A1/en
Priority to CA2909117A priority patent/CA2909117A1/en
Priority to US14/783,038 priority patent/US20160051526A1/en
Priority to CN201480030418.5A priority patent/CN105555364A/en
Priority to EP14717821.4A priority patent/EP2983713A1/en
Priority to PCT/GB2014/051108 priority patent/WO2014167326A1/en
Priority to HK16109376.7A priority patent/HK1221190A1/en
Priority to US14/782,975 priority patent/US20160068527A1/en
Priority to HK16109377.6A priority patent/HK1221166A1/en
Priority to RU2015145135A priority patent/RU2015145135A/en
Priority to JP2016507058A priority patent/JP2016516761A/en
Priority to GB1406396.0A priority patent/GB2516138C/en
Priority to CN201480030407.7A priority patent/CN105431172A/en
Priority to AU2014252807A priority patent/AU2014252807A1/en
Priority to EP14717820.6A priority patent/EP2983788A1/en
Priority to PCT/GB2014/051109 priority patent/WO2014167327A1/en
Priority to CA2909111A priority patent/CA2909111A1/en
Priority to RU2015145134A priority patent/RU2015145134A/en
Priority to ZA201507718A priority patent/ZA201507718B/en
Priority to ZA2015/07724A priority patent/ZA201507724B/en
Ceased legal-status Critical Current

Links

GB201306413A 2013-04-09 2013-04-09 The local treatment of ophthalmic diseases Ceased GB201306413D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB201306413A GB201306413D0 (en) 2013-04-09 2013-04-09 The local treatment of ophthalmic diseases
RU2015145134A RU2015145134A (en) 2013-04-09 2014-04-09 LOCAL TREATMENT OF INFLAMMATORY OPHTHALMIC DISEASES
US14/782,975 US20160068527A1 (en) 2013-04-09 2014-04-09 The Treatment of Inflammatory Disorders
RU2015145135A RU2015145135A (en) 2013-04-09 2014-04-09 TREATMENT OF INFLAMMATORY DISORDERS
AU2014252808A AU2014252808A1 (en) 2013-04-09 2014-04-09 The treatment of inflammatory disorders
CA2909117A CA2909117A1 (en) 2013-04-09 2014-04-09 The treatment of inflammatory disorders
US14/783,038 US20160051526A1 (en) 2013-04-09 2014-04-09 The Local Treatment of Inflammatory Ophthalmic Disorders
CN201480030418.5A CN105555364A (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
EP14717821.4A EP2983713A1 (en) 2013-04-09 2014-04-09 The treatment of inflammatory disorders
PCT/GB2014/051108 WO2014167326A1 (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
HK16109376.7A HK1221190A1 (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
JP2016507059A JP2016516762A (en) 2013-04-09 2014-04-09 Treatment of inflammatory disorders
HK16109377.6A HK1221166A1 (en) 2013-04-09 2014-04-09 The treatment of inflammatory disorders
GB1406390.3A GB2516137B (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
JP2016507058A JP2016516761A (en) 2013-04-09 2014-04-09 Topical treatment of inflammatory eye diseases
GB1406396.0A GB2516138C (en) 2013-04-09 2014-04-09 The treatment of inflammatory disorders
CN201480030407.7A CN105431172A (en) 2013-04-09 2014-04-09 Treatment of Inflammatory Conditions
AU2014252807A AU2014252807A1 (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
EP14717820.6A EP2983788A1 (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
PCT/GB2014/051109 WO2014167327A1 (en) 2013-04-09 2014-04-09 The treatment of inflammatory disorders
CA2909111A CA2909111A1 (en) 2013-04-09 2014-04-09 The local treatment of inflammatory ophthalmic diseases
ZA2015/07724A ZA201507724B (en) 2013-04-09 2015-10-15 The treatment of inflammatory disorders
ZA201507718A ZA201507718B (en) 2013-04-09 2015-10-15 The local treatment of inflammatory ophthalmic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201306413A GB201306413D0 (en) 2013-04-09 2013-04-09 The local treatment of ophthalmic diseases

Publications (1)

Publication Number Publication Date
GB201306413D0 true GB201306413D0 (en) 2013-05-22

Family

ID=48483609

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201306413A Ceased GB201306413D0 (en) 2013-04-09 2013-04-09 The local treatment of ophthalmic diseases

Country Status (1)

Country Link
GB (1) GB201306413D0 (en)

Similar Documents

Publication Publication Date Title
PT3811943T (en) Compound for use in the treatment of ocular disorders
IL243976B (en) Kdm1a inhibitors for the treatment of disease
PL3122878T3 (en) Mrna therapy for the treatment of ocular diseases
SG10201912275YA (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3kd related disorders
IL243485A0 (en) Methods for the treatment or prevention of ophthalmological conditions
EP2991670B8 (en) Sobetirome in the treatment of myelination diseases
PL2968218T3 (en) Combination for the treatment of parkinson's disease
IL240931A0 (en) Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
LT3626270T (en) Treatment of cardiovascular diseases
IL250990A0 (en) Human therapeutic agents
PL3210973T3 (en) Heteroaryl compounds for the treatment of ophthalmic diseases
EP3061455A4 (en) Therapeutic agent for ocular disease or prophylactic agent for ocular disease
ZA201507718B (en) The local treatment of inflammatory ophthalmic diseases
ZA201603117B (en) Withanolides useful for the treatment of neurodegenerative diseases
IL243637B (en) Ppar-sparing compounds for the treatment of metabolic diseases
HUE051295T2 (en) Modified fibroblast growth factors-1 for the treatment of eye diseases
EP3046629A4 (en) Treatment of inflammatory skin disease
IL259381B (en) Miravegron for the treatment of retinal diseases
EP3089984A4 (en) Novel compounds for the treatment of cancer and inflammatory diseases
HK40032828A (en) Methods for the treatment of mitochondrial disease
PL3016948T3 (en) 2-acylaminothiazoles for the treatment of cancer
GB201306413D0 (en) The local treatment of ophthalmic diseases
GB201321628D0 (en) Treatment of disease
GB201308302D0 (en) Cream for treatment of the skin

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)